Notice2022-01271
Notice of Award of a Single-Source Cooperative Agreement To Fund National Institute for Communicable Diseases (NICD), South Africa
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 24, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $5,000,000 for Year 1 of funding to the National Institute for Communicable Diseases (NICD), South Africa. The award will provide accurate, timely, and high-quality strategic information to enable the South African Government (SAG) to track critical infectious disease pathogens, monitor interventions, and inform policy and programming to reduce disease transmission and burden. Annual award amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 15 (Monday, January 24, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Pages 3541-3542]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01271]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
National Institute for Communicable Diseases (NICD), South Africa
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $5,000,000 for Year 1 of funding to the National
Institute for Communicable Diseases (NICD), South Africa. The award
will provide accurate, timely, and high-quality strategic information
to enable the South African Government (SAG) to track critical
infectious disease pathogens, monitor interventions, and inform policy
and programming to reduce disease transmission and burden. Annual award
amounts for years 2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2022, through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Dr. Karidia Diallo, Center for Global
Health, Centers for Disease Control and
[[Page 3542]]
Prevention, 100 Totius Street, Groenkloof, Pretoria, South Africa,
Telephone: 800-232-6348, Email: <a href="/cdn-cgi/l/email-protection#167372632f5675727538717960"><span class="__cf_email__" data-cfemail="dfbabbaae69fbcbbbcf1b8b0a9">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will support the SAG
in four broad areas of public health surveillance and response:
Communicable (e.g., HIV and TB) and non-communicable disease
surveillance, public health laboratory capacity, public health
workforce development, and global health security. The NICD, under the
National Public Health Institute of South Africa (NAPHISA), is in a
unique position to conduct this work, through an act of parliament
mandating the organization to provide microbiology, virology,
epidemiology, surveillance and public health research and training to
support the government's response to communicable disease threats.
Summary of the Award
Recipient: National Institute for Communicable Diseases (NICD),
South Africa.
Purpose of the Award: The purpose of this award is to provide
accurate, timely, and high-quality strategic information to enable the
SAG to track critical infectious disease pathogens, monitor
interventions, and inform policy and programming to reduce disease
transmission and burden.
Amount of Award: The approximate year 1 funding amount will be
$5,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the
availability of funds. Annual award amounts for years 2-5 will be set
at continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Period of Performance: September 30, 2022, through September 29,
2027.
Dated: January 19, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-01271 Filed 1-21-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 24, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.